Literature DB >> 11988079

Isolation and characterization of a polymerized prion protein.

Bao-Yuan Lu1, Jui-Yoa Chang.   

Abstract

A polymerized form of recombinant mouse prion protein (mPrP) domain 23-231 [mPrP-(23-231)], designated mPrP-z, was generated at acidic pH (pH 2-5) in the presence of selected concentrations of denaturant (2 M guanidinium chloride or 5 M urea). This isoform of mPrP is stable in acidic solution after removal of denaturant. It can be isolated and purified using reversed-phase HPLC or size-exclusion HPLC. mPrP-z bears structural properties that partially resemble those of scrapie prion. Unlike the native mPrP-(23-231) (mPrP-N), mPrP-z exhibits a high content of beta-sheet structure, as shown by CD spectroscopy, and exists as an oligomer with an approximate molecular mass of 340000 Da, as measured by light scattering. However, similarly to mPrP-N, mPrP-z contains the intact disulphide bond and is sensitive to digestion by proteinase K.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988079      PMCID: PMC1222548          DOI: 10.1042/bj3640081

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

Review 1.  Prion protein and the transmissible spongiform encephalopathy diseases.

Authors:  B Chesebro
Journal:  Neuron       Date:  1999-11       Impact factor: 17.173

2.  Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain.

Authors:  M Horiuchi; G S Baron; L W Xiong; B Caughey
Journal:  J Biol Chem       Date:  2001-02-01       Impact factor: 5.157

3.  Mimicking dominant negative inhibition of prion replication through structure-based drug design.

Authors:  V Perrier; A C Wallace; K Kaneko; J Safar; S B Prusiner; F E Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.

Authors:  W Swietnicki; M Morillas; S G Chen; P Gambetti; W K Surewicz
Journal:  Biochemistry       Date:  2000-01-18       Impact factor: 3.162

5.  Testing times for BSE.

Authors:  Q Schiermeier
Journal:  Nature       Date:  2001-02-08       Impact factor: 49.962

6.  Structural intermediates in the putative pathway from the cellular prion protein to the pathogenic form.

Authors:  K Jansen; O Schäfer; E Birkmann; K Post; H Serban; S B Prusiner; D Riesner
Journal:  Biol Chem       Date:  2001-04       Impact factor: 3.915

7.  Oxidative folding of murine prion mPrP(23-231).

Authors:  B Y Lu; P J Beck; J Y Chang
Journal:  Eur J Biochem       Date:  2001-07

8.  Thioredoxin converts the Syrian hamster (29-231) recombinant prion protein to an insoluble form.

Authors:  J R Requena; R L Levine
Journal:  Free Radic Biol Med       Date:  2001-01-15       Impact factor: 7.376

9.  The role of disulfide bridge in the folding and stability of the recombinant human prion protein.

Authors:  N R Maiti; W K Surewicz
Journal:  J Biol Chem       Date:  2000-11-07       Impact factor: 5.157

10.  On the mechanism of alpha-helix to beta-sheet transition in the recombinant prion protein.

Authors:  M Morillas; D L Vanik; W K Surewicz
Journal:  Biochemistry       Date:  2001-06-12       Impact factor: 3.162

View more
  5 in total

1.  Interaction of prion protein with small highly structured RNAs: detection and characterization of PrP-oligomers.

Authors:  Sara Vasan; Phyllus Y Mong; Abraham Grossman
Journal:  Neurochem Res       Date:  2006-06-02       Impact factor: 3.996

2.  Diversity in prion protein oligomerization pathways results from domain expansion as revealed by hydrogen/deuterium exchange and disulfide linkage.

Authors:  Frederic Eghiaian; Thorsten Daubenfeld; Yann Quenet; Marieke van Audenhaege; Anne-Pascale Bouin; Guillaume van der Rest; Jeanne Grosclaude; Human Rezaei
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-18       Impact factor: 11.205

3.  Physical and functional antagonism between tumor suppressor protein p53 and fortilin, an anti-apoptotic protein.

Authors:  Yanjie Chen; Takayuki Fujita; Di Zhang; Hung Doan; Decha Pinkaew; Zhihe Liu; Jiaxin Wu; Yuichi Koide; Andrew Chiu; Curtis Chen-Jen Lin; Jui-Yoa Chang; Ke-He Ruan; Ken Fujise
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

Review 4.  Insoluble cellular prion protein and its association with prion and Alzheimer diseases.

Authors:  Wen-Quan Zou; Xiaochen Zhou; Jue Yuan; Xiangzhu Xiao
Journal:  Prion       Date:  2011-07-01       Impact factor: 3.931

5.  Structure of prion β-oligomers as determined by short-distance crosslinking constraint-guided discrete molecular dynamics simulations.

Authors:  Jason J Serpa; Konstantin I Popov; Evgeniy V Petrotchenko; Nikolay V Dokholyan; Christoph H Borchers
Journal:  Proteomics       Date:  2021-09-16       Impact factor: 5.393

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.